M3, Inc.

2413.T
Health Information Services
2026/11/20 13:29 Updated
Market Cap: $7.1B (¥1.1T)
Stock Price: $10.76 (¥1,708)
Exchange Rate: 1 USD = ¥158.73

Notice of Change of Head Office Location

A consolidated subsidiary, Elan, has revised and published its full-year earnings forecast. There is no impact on M3, Inc.'s consolidated earnings forecast. The new forecast shows net sales of 61,500 hundred million yen, operating income of 5,500 hundred million yen, ordinary income of 5,750 hundred million yen, net income attributable to owners of parent of 1,500 hundred million yen (changes from prior forecast: +700/+500/+750/-1,700), and net income per share of 24 yen 75 sen. The reason for the revision is that overall progress is exceeding the initial plan. However, due to recording of special losses, the company's own net income is expected to be revised downward.

Importance:
Page Updated: November 20, 2026
IR Disclosure Date: November 20, 2026

Key Figures

  • Net Sales: 60,800→61,500 hundred million yen
  • Operating Income: 5,000→5,500 hundred million yen
  • Net Income Attributable to Owners of Parent: 3,200→1,500 hundred million yen

AI要約

Facts and Impact

This notice concerns the revision of the full-year earnings forecast of consolidated subsidiary Elan. M3, Inc.'s consolidated earnings forecast itself has not been revised; the document only reports the fact that Elan has published a revised forecast. In the new forecast, net sales are 61,500 hundred million yen, operating income is 5,500 hundred million yen, ordinary income is 5,750 hundred million yen, and net income attributable to owners of parent is 1,500 hundred million yen. Compared with the previous forecast, net sales and profits are revised upward, while net income attributable to owners of parent is substantially revised downward.

Impact on Shareholders and Outlook

Elan's forecast revision will affect M3, Inc.'s consolidated results, but it is stated that there is no impact on the company's own forecasts. Reasons for the revision include strong demand from facilities that introduced the "CS Set," which is expected to increase net sales and ordinary income, selling, general and administrative expenses expected to be below plan, and recognition of gains from investment partnership operations. On the other hand, goodwill impairment and other items will be recorded as special losses, so final net income is expected to decrease. Going forward, consolidated indicators may continue to be affected depending on Elan's developments.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

M3, Inc.

Company overview · Stock price · Financial data · All IR

View company page →